BioPharma Resources

Drug Trial Radar · NCT03423173

Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Demonstrate Lot-to-Lot Consistency of 3 Lots of a Tetravalent Dengue Vaccine Candidate in Healthy Adults in Non-Endemic Country(Ies) for Dengue

Last checked: Nov 19, 2026Latest source record: Oct 20, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 923 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

923

Actual

Start

Feb 12, 2018

Primary completion

Aug 3, 2018

Study completion Jan 14, 2019

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Feb 6, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate lot-to-lot consistency in terms of equivalence of the immune responses induced by 3 consecutive TDV lots in healthy participants aged 18 to 60 years in non-endemic country(ies) for dengue.

Conditions

  • Dengue Fever

Interventions

  • TAK-003Biological

    TDV subcutaneous injection

  • PlaceboBiological

    TDV Placebo-matching normal saline (0.9% NaCl) subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Geometric Mean Titers (GMTs) of Neutralizing Antibodies for Each of the 4 Dengue Serotypes at Day 120 in the Immunogenicity SubsetTime frame: 1 month post second dose (Day 120)

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Optimal Research

    Huntsville, Alabama

  • Anaheim Clinical Trials, LLC

    Anaheim, California

  • Advanced Clinical Research

    Boise, Idaho

  • Optimal Research

    Peoria, Illinois

  • Synexus Limited- Council Bluffs

    Council Bluffs, Iowa

  • Heartland Research Associates LLC - Augusta

    Augusta, Kansas

  • Heartland Research Associates LLC

    Park City, Kansas

  • Optimal Research

    Rockville, Maryland

  • Synexus Limited - Minneapolis

    Edina, Minnesota

  • Synexus Limited - St. Louis

    St Louis, Missouri

  • Clinical Research Center of Nevada

    Las Vegas, Nevada

  • Synexus Limited - Columbus

    Columbus, Ohio

  • Advanced Clinical Research

    Salt Lake City, Utah

  • Advanced Clinical Research

    West Jordan, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.